<DOC>
	<DOC>NCT01634100</DOC>
	<brief_summary>The objectives of the trial are to investigate the effect of concurrent administration of rifampicin and probenecid on the pharmacokinetics of empagliflozin.</brief_summary>
	<brief_title>Drug-interaction Trial in Healthy Subjects With Oral Administration of Empagliflozin (BI 10773), Rifampicin and Probenecid</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Empagliflozin</mesh_term>
	<mesh_term>Probenecid</mesh_term>
	<criteria>Inclusion criteria: 1. healthy male and female subjects Exclusion criteria: 1. any relevant deviation from healthy conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>